Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant- Dominant Periods in Korea

被引:23
|
作者
Choi, Soo -Han [1 ]
Choi, Jae Hong [2 ]
Lee, Joon Kee [3 ]
Eun, Byung-Wook [4 ]
Ha Song, Seung [5 ]
Ahn, Bin [5 ]
Kim, Ye Kyung [5 ]
Yun, Ki Wook [5 ,6 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Pediat, Busan, South Korea
[2] Jeju Natl Univ, Sch Med, Dept Pediat, Jeju, South Korea
[3] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Dept Pediat, Cheongju, South Korea
[4] Nowon Eulji Univ Hosp, Dept Pediat, Seoul, South Korea
[5] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Dept Pediat, 101 Daehak Ro, Seoul 03080, South Korea
关键词
COVID-19; SARS-CoV-2; Variants; SARS-CoV-2 Omicron Variant; SARS-CoV-2 Delta Variant; Child; Adolescent; LABORATORY-CONFIRMED COVID-19-COVID-NET; 14; STATES; HOSPITALIZATIONS; TRANSMISSION;
D O I
10.3346/jkms.2023.38.e65
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Data on the clinical characteristics of pediatric patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection are limited. We aimed to evaluate the clinical features and outcomes of children with SARS-CoV-2 infection before and after omicron variant dominance in Korea.Methods: A multicenter retrospective cohort study was conducted in hospitalized patients aged <= 18 years with laboratory-confirmed SARS-CoV-2 infection at five university hospitals in South Korea. The study periods were divided into the delta (from August 23, 2021 to January 2, 2022) and omicron (from January 30 to March 31, 2022).Results: In total, 612 hospitalized patients were identified (211, delta; 401, omicron). During the omicron and delta periods, the proportions of individuals with serious illness (moderate, severe, and critical severity) were 21.2% and 11.8%, respectively (P = 0.034). Compared with the delta period, the proportions of patients with moderate illness increased significantly in the age groups of 0-4 years (14.2% vs. 3.4%) and 5-11 years (18.6% vs. 4.2%) during the omicron period. During the two periods, the proportions of patients with complex chronic diseases (delta, 16.0% vs. 4.3%, P = 0.040; omicron, 27.1% vs. 12.7%; P = 0.002), respiratory diseases except for asthma (delta, 8.0% vs. 0.0%, P = 0.013; omicron, 9.4% vs. 1.6%; P = 0.001), and neurologic diseases (delta, 28.0% vs. 3.2%, P < 0.001; omicron, 40.0% vs. 5.1%, P < 0.001) were significantly higher in patients with serious illness than in those with non -serious illness. During the delta period, the risk for serious illness was higher among patients with obesity (adjusted odds ratio [aOR], 8.18; 95% confidence interval [CI], 2.80-27.36) and neurologic diseases (aOR, 39.43; 95% CI, 6.90-268.3) and aged 12-18 years (aOR, 3.92; 95% CI, 1.46-10.85). However, the presence of neurologic disease (aOR, 9.80; 95% CI, 4.50-22.57) was the only risk factor for serious illness during the omicron period. During the omicron period, the proportions of patients with croup (11.0% vs. 0.5%) and seizures (13.2% vs. 2.8%) increased significantly compared with the delta period.Conclusion: Compared with the delta period, the proportions of young children and patients with complex comorbidities were higher during the omicron period in Korea. Patients with complex chronic diseases, especially neurologic diseases, had a high risk of severe coronavirus disease 2019 in the two distinct variant-dominant periods.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The effect of the delta SARS-CoV-2 variant on maternal infection and pregnancy
    Samara, Athina
    Khalil, Asma
    O'Brien, Patrick
    Herlenius, Eric
    ISCIENCE, 2022, 25 (05)
  • [32] Response of antibody titers to SARS-CoV-2 vaccination and clinical outcomes during the predominance of the Omicron variant in Colombia
    Montero, Camilo
    Torres, Rodolfo
    Reina, Maricely
    Flechas, Jonth
    Andrade, David
    Moreno, Sebastian
    Granados, Camila
    Yomayusa, Nancy
    SAGE OPEN MEDICINE, 2023, 11
  • [33] Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan
    Li, Y.
    Yamamoto, S.
    Oshiro, Y.
    Inamura, N.
    Nemoto, T.
    Horii, K.
    Takeuchi, J. S.
    Mizoue, T.
    Konishi, M.
    Ozeki, M.
    Sugiyama, H.
    Sugiura, W.
    Ohmagari, N.
    JOURNAL OF HOSPITAL INFECTION, 2023, 134 : 97 - 107
  • [34] Alterations in smell or taste in individuals infected with SARS-CoV-2 during periods of Omicron variant dominance
    Song, Jian
    Jing, Qi
    Zhu, Enzhao
    Liu, Qidong
    Fei, Miaomiao
    Zhang, Hui
    An, Guanghui
    Cao, Silu
    Tang, Jinxuan
    Xu, Guanghui
    Liu, Yi
    Ai, Zisheng
    Tao, Yingna
    Li, Cheng
    Xiong, Lize
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 278 - 284
  • [35] Clinical and laboratory characteristics of children with SARS-CoV-2 infection
    Berksoy, Emel
    Kanik, Ali
    Cicek, Alper
    Bardak, Sefika
    Elibol, Pelin
    Demir, Gulsah
    Yilmaz, Nisel
    Nalbant, Tugce
    Gokalp, Gamze
    Yilmaz Ciftdogan, Dilek
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3674 - 3681
  • [36] Effectiveness of BNT162b2 vaccine against symptomatic SARS-CoV-2 infection in children aged 5-11 years in Japan during Omicron variant predominate periods
    Hara, Megumi
    Ohta, Yuko
    Fusazaki, Naoki
    Hirota, Yoshio
    JOURNAL OF EPIDEMIOLOGY, 2024, 34 (05) : 205 - 210
  • [37] Molecular detection of SARS-CoV-2 and differentiation of Omicron and Delta variant strains
    Tsui, Wai Ning Tiffany
    Hamill, Vaughn
    Noll, Lance
    Lu, Nanyan
    Porter, Elizabeth Poulsen
    Harbidge, Donald
    Cox, Emily
    Richardson, Claire
    Gray, Mark
    Sebhatu, Tesfaalem
    Goerl, Kyle
    Brown, Susan
    Hanzlicek, Gregg
    Retallick, Jamie
    Bai, Jianfa
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (05) : E1618 - E1631
  • [38] SARS-CoV-2 infection outcomes associated with the Delta variant: A prospective cohort study
    Gallant, Maxime
    Rioux-Perreault, Christine
    Lemaire-Paquette, Samuel
    Piche, Alain
    JOURNAL OF THE ASSOCIATION OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASE CANADA (JAMMI), 2022, 8 (01): : 49 - 56
  • [39] Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient
    Alisoltani, Arghavan
    Simons, Lacy M.
    Agnes, Maria Francesca Reyes
    Heald-Sargent, Taylor A.
    Muller, William J.
    Kociolek, Larry K.
    Hultquist, Judd F.
    Lorenzo-Redondo, Ramon
    Ozer, Egon A.
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [40] SARS-CoV-2 During Omicron Variant Predominance Among Infants Born to People With SARS-CoV-2
    Gosdin, Lucas
    Chang, Daniel
    Olsen, Emily O'Malley
    Lewis, Elizabeth L. L.
    Wingate, Heather
    Ojo, Kristen D. D.
    Shephard, Hanna
    Sokale, Ayomide
    Mobley, Evan L. L.
    Delgado-Lopez, Camille
    Hall, Aron J. J.
    Gilboa, Suzanne M. M.
    Tong, Van T. T.
    Woodworth, Kate R. R.
    PEDIATRICS, 2023, 151 (05)